Covered recipient · General Payments record
BROCK KING
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$26,163.74
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $432.36 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TELA Bio, Inc. | $200.41 | 4 |
| ABBVIE INC. | $65.34 | 3 |
| PolyNovo North America LLC | $44.31 | 2 |
| Hologic Sales and Service, LLC | $24.61 | 1 |
| TAS Medical, Inc. | $19.46 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.12 | 1 |
| Solventum Corporation | $15.87 | 1 |
| Novo Nordisk AS | $15.14 | 1 |
| Smith & Nephew, Inc. | $14.47 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.97 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077430 | CMS |
| ABBVIE INC. | $23.54 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077432 | CMS |
| ABBVIE INC. | $19.83 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077434 | CMS |
| Boston Scientific Corporation | $13.63 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092590741 | CMS |
| Hologic Sales and Service, LLC | $24.61 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084886747 | CMS |
| Novo Nordisk Inc | $15.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096921912 | CMS |
| PolyNovo North America LLC | $21.70 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148181755 | CMS |
| PolyNovo North America LLC | $22.61 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148181757 | CMS |
| Smith+Nephew, Inc. | $14.47 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149526891 | CMS |
| Solventum Corporation | $15.87 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144061212 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.12 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137602916 | CMS |
| TAS Medical, Inc. | $19.46 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153994258 | CMS |
| TELA Bio, Inc. | $10.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154184681 | CMS |
| TELA Bio, Inc. | $23.65 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154184679 | CMS |
| TELA Bio, Inc. | $82.45 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154184675 | CMS |
| TELA Bio, Inc. | $84.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154184677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.